It used to be Peter Rost vs. John Mack, but now it seems that Peter’s popularity with some other pharma bloggers may be slipping following the release of his new book, The Killer Drug. Bloggers are protesting Peter’s “shameless self promotion” on his own blog and newly acquired BrandweekNRX.
A comment on Peter’s post “Is BrandweekNRX boring?” put it this way:
The only thing that’s boring is this tit-for-tat between you and he-who-now-must-not-be-named. I don’t know about anybody else, but I find it to be an incredibly childish and ridiculous pissing contest that’s making you both look bad. I read this blog for news and analysis, not he-said he-said, and I’m coming back less and less. Ignore him and get on with what you came here to do.
p.s. The boasting is also getting tiresome.
p.p.s. I told “him” the same thing and his cheery reply was ‘good riddance.’ Obviously his desire to attack you goes beyond his desire to keep reader numbers up. On a safety note, Peter, it may not be a good idea to indulge in his obsession.
One good thing that has come out of this quarrel is some interesting Photoshopping.116